Metraipolis › archive › dc_5107e0d628fe

Real-world outcomes in patients with tumor-induced osteomalacia treated vs not treated with burosumab — Europe PMC PMID:42576983

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42576983
DOI
10.1210/jendso/bvag165
License (as archived)
solo-consultazione
Archived
2026-10-08T00:14:26.397Z
SHA-256 of the archived text
7947004fa5c58f63fc77001c7eff5278a66c7a59350068f627f88371e05d5c5b
Stable URL of this page
https://metraipolis.com/documento/dc_5107e0d628fe

How to cite

Real-world outcomes in patients with tumor-induced osteomalacia treated vs not treated with burosumab — Europe PMC PMID:42576983 — Europe PMC (en), https://europepmc.org/article/MED/42576983 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5107e0d628fe (Metraipolis archive dc_5107e0d628fe, sha256 7947004fa5c58f63fc77001c7eff5278a66c7a59350068f627f88371e05d5c5b)
BibTeX
@misc{dc5107e0d628fe,
  title = {Real-world outcomes in patients with tumor-induced osteomalacia treated vs not treated with burosumab — Europe PMC PMID:42576983},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42576983},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5107e0d628fe; sha256 7947004fa5c58f63fc77001c7eff5278a66c7a59350068f627f88371e05d5c5b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42576983. Agents can read the archived copy with the MCP tool read_document.